compounds for treating neurodegenerative …

compounds for treating neurodegenerative …

ID:12748551

大小:2.53 MB

页数:181页

时间:2018-07-18

compounds for treating neurodegenerative …_第1页
compounds for treating neurodegenerative …_第2页
compounds for treating neurodegenerative …_第3页
compounds for treating neurodegenerative …_第4页
compounds for treating neurodegenerative …_第5页
资源描述:

《compounds for treating neurodegenerative …》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库

1、COMPOUNDSFORTREATINGNEURODEGENERATIVEDISEASESBACKGROUNDOFTHEINVENTION[0001]FIELDOFTHEINVENTION[0002]Thepresentinventionrelatestoorganiccompoundsusefulforinhibitionofβ-secretaseenzymaticactivityandthetherapyand/orprophylaxisofneurodegenerativediseasesassociatedtherewith.Moreparticularl

2、y,certainspirotetrahyrdonaphthalenecompoundsusefulinthetreatmentandpreventionofneurodegenerativediseases,suchasAlzheimer'sdisease,areprovidedherein.[0003]DESCRIPTIONOFTHESTATEOFTHEART[0004]Alzheimer'sdisease(AD)isaneurologicaldisorderthoughttobeprimarilycausedbyamyloidplaques,anaccumu

3、lationofabnormalproteindepositsinthebrain.Itisbelievedthatanincreaseintheproductionandaccumulationofamyloidbetapeptides(alsoreferredtoasAβorA-beta)inplaquesleadstonervecelldeath,whichcontributestothedevelopmentandprogressionofAD.Lossofnervecellsduetoamyloidplaquesinstrategicbrainareas

4、,inturn,causesreductionintheneurotransmittersandimpairmentofmemory.Theproteinsprincipallyresponsiblefortheplaquebuildupincludeamyloidprecursorprotein(APP)andpresenilinIandII(PSIandPSII).MutationsineachofthesethreeproteinshavebeenobservedtoenhanceproteolyticprocessingofAPPviaanintracel

5、lularpathwaythatproducesAβpeptidesrangingfrom39to43aminoacids.TheAβ1-42fragmenthasaparticularlyhighpropensityofformingaggregatesduetotwoveryhydrophobicaminoacidresiduesatitsC-terminus.Thus,Aβ1-42fragmentisbelievedtobemainlyresponsiblefortheinitiationofneuriticamyloidplaqueformationinA

6、Dandisthereforeactivelybeingpursuedasatherapeutictarget.Anti-AβantibodieshavebeenshowntoreversethehistologicandcognitiveimpairmentsinmicewhichoverexpressAβandarecurrentlybeingtestedinhumanclinicaltrials.Effectivetreatmentrequiresanti-Aβantibodiestocrosstheblood-brainbarrier(BBB),howev

7、er,antibodiestypicallycrosstheBBBverypoorlyandaccumulateinthebraininlowconcentration.[0005]DifferentformsofAPPrangeinsizefrom695-770aminoacids,localizetothecellsurface,andhaveasingleC-terminaltransmembranedomain.AβisderivedfromaregionofAPPadjacenttoandcontainingaportionofthetransmembr

8、anedo

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。